29 Jul, 2025
\n \n \n \nNDORMS has been awarded the designation of a EULAR Centre of Excellence for a third consecutive term. This prestigious award is a recognition of the department\u2019s contribution to advancing the science of rheumatic and musculoskeletal diseases.
\n \n\n \n \n4 Jul, 2025
\n \n \n \nResearchers have been able to see what happens in the inflamed joints of children with arthritis, giving insight into why treatments affect children differently.
\n \n\n \n \n30 Jun, 2025
\n \n \n \nKennedy researchers have uncovered new clues about how immune memory exacerbates inflammation in rheumatoid arthritis, which could lead to better ways to control the disease.
\n \n\n \n \n25 Jun, 2025
\n \n \n \nKennedy DPhil student Chrissy Bolton has been awarded Best Abstract in Basic and Translational Science at the European Alliance of Associations for Rheumatology 2025 (EULAR) conference.
\n \n\n \n \n19 Jun, 2025
\n \n \n \nKennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs) - a class of cancer immunotherapy drugs. The findings may help unlock the full potential of TcEs and revolutionise cancer treatment for patients.
\n \n\n \n \n16 Jun, 2025
\n \n \n \nGhada Alsaleh and Alex Clarke have been awarded the title of Associate Professor by the University of Oxford.
\n \n\n \n \n15 May, 2025
\n \n \n \nA team at NDORMS, University of Oxford has successfully administered a pioneering treatment to a patient with XIAP deficiency, a rare genetic disorder.
\n \n\n \n \n1 May, 2025
\n \n \n \nResearchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues\u2014addressing a major challenge in current immunotherapy.
\n \n\n \n \n25 Apr, 2025
\n \n \n \nA new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
\n \n\n \n \n28 Mar, 2025
\n \n \n \nNew research from the Kennedy Institute has revealed how two important proteins, TBK1 and IKKe, play a crucial role in preventing premature cell death, which can lead to serious inflammation in the body. The findings are particularly relevant for people with a mutation in the TBK1 gene who often develop multiorgan inflammation caused by excessive cell death even in the absence of any infection.
\n \n\n \n \n17 Mar, 2025
\n \n \n \nResearchers at the Kennedy Institute have developed a new computational framework that allows simultaneous analysis of gene expression and mechanical forces within cells and tissues, uncovering insights into how the interplay between transcriptional and mechanical signals guides processes such as cell fate decisions or the formation of spatially distinct tissue compartments.
\n \n\n \n \n7 Feb, 2025
\n \n \n \nStudy shows why there are differences in prognosis between different pancreatic tumours and identifies potential avenues for improved treatment approaches.
\n \n\n \n \n21 Jan, 2025
\n \n \n \nAudrey Gerard, an Associate Professor of Immune Cell Dynamics and Principal Investigator at the Kennedy Institute of Rheumatology, is working to understand how the immune response interacts with and shapes tumours.
\n \n\n \n \n20 Jan, 2025
\n \n \n \nThe\u202fAmerican Association of Immunologists (AAI)\u202fhas recognised the outstanding work of the Kennedy Institute\u2019s Professor of Molecular Immunology Michael Dustin\u202fby naming him a Distinguished Fellow of AAI.
\n \n\n \n \n3 Jan, 2025
\n \n \n \nA new study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response.
\n \n\n \n \n9 Dec, 2024
\n \n \n \nPaul joined the Kennedy Institute in September 2024 as part of the Newton-Abraham Visiting Professorship, a prestigious award given by the University of Oxford to the most distinguished scholars in the biological, chemical or medical sciences.
\n \n\n \n \n17 Sep, 2024
\n \n \n \nDr Kate Coldwell has joined the Oxford Centre for Microbiome Studies at the Kennedy Institute to study the links between liver disease and gut bacteria, having been awarded the Daphne Jackson Fellowship, co-funded by the Kennedy Trust for Rheumatology Research (KTRR) and the Medical Research Council.
\n \n\n \n \n16 Sep, 2024
\n \n \n \nProfessor Sir Ravinder Maini and Professor Sir Marc Feldmann have jointly received The Royal Society\u2019s Royal Medal (Applied) for inventing anti-TNF therapy to treat rheumatoid arthritis (RA), bringing it from bench to bedside in one of the biggest success stories of modern medicine.
\n \n\n \n \n21 Aug, 2024
\n \n \n \nIrina Udalova has received funding from Cancer Research UK (CRUK) to study the diverse role of neutrophils in ovarian cancer.
\n \n\n \n \n4 Jun, 2024
\n \n \n \nAlan has spent two months at the Kennedy Institute as a guest of Professor Dame Fiona Powrie. During his visit he has spent his time collaborating with researchers at the Kennedy and other departments in the University, and mentoring young investigators on their career development.
\n \n\n \n \n